Nephrology Dialysis Transplantation

Foreword
pp. viii1-viii1(1)
Author: Macdougall I.C.

Anaemia and the heart: what's new in 2003?
pp. viii13-viii16(4)
Author: Foley R.N.

Anaemia and inflammation: what are the implications for the nephrologist?
pp. viii17-viii22(6)
Author: Stenvinkel P.

Left ventricular hypertrophy: why does it happen?
pp. viii2-viii6(5)
Author: London G.M.

Hyporesponsiveness to erythropoietic therapy in uraemic patients with secondary hyperparathyroidism: what is the evidence base?
pp. viii23-viii23(1)
Authors: Drüeke T.B.

Intravenous iron as adjuvant therapy: a two-edged sword?
pp. viii24-viii28(5)
Author: Cavill I.

Dialysis adequacy and response to erythropoietic agents: what is the evidence base?
pp. viii29-viii35(7)
Authors: Locatelli F.; Vecchio L.D.

Once-weekly erythropoietic therapy: is there a difference between the available preparations?
pp. viii36-viii36(1)
Author: Macdougall I.C.

Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin
pp. viii37-viii41(5)
Author: Casadevall N.

The cardio–renal anaemia syndrome: does it exist?
pp. viii7-viii12(6)
Authors: Silverberg D.; Wexler D.; Blum M.; Wollman Y.; Iaina A.